Correlation Between Virax Biolabs and Mink Therapeutics
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Mink Therapeutics, you can compare the effects of market volatilities on Virax Biolabs and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Mink Therapeutics.
Diversification Opportunities for Virax Biolabs and Mink Therapeutics
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Virax and Mink is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Mink Therapeutics go up and down completely randomly.
Pair Corralation between Virax Biolabs and Mink Therapeutics
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 2.01 times more return on investment than Mink Therapeutics. However, Virax Biolabs is 2.01 times more volatile than Mink Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Mink Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 1,390 in Virax Biolabs Group on August 23, 2024 and sell it today you would lose (1,206) from holding Virax Biolabs Group or give up 86.76% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Mink Therapeutics
Performance |
| Timeline |
| Virax Biolabs Group |
| Mink Therapeutics |
Virax Biolabs and Mink Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Mink Therapeutics
The main advantage of trading using opposite Virax Biolabs and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.| Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. ZyVersa Therapeutics | Virax Biolabs vs. Sonnet Biotherapeutics Holdings | Virax Biolabs vs. Zura Bio Limited |
| Mink Therapeutics vs. Affimed NV | Mink Therapeutics vs. Adaptimmune Therapeutics Plc | Mink Therapeutics vs. Sangamo Therapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |